MAGEA1 and hepatocellular carcinoma: According to these data, KK-LC-1 could be categorised as a CTA, but the expression rate of KK-LC-1 in gastric cancer and TNBC is not consistent with the traditional concept of CTAs except for melanoma antigen (MAGE)-A1 in hepatic cell carcinoma (HCC).